Key facts
- This page summarizes Zachary Rome's Form 4 filing for PaxMedica, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Mar 2024, 16:48.
Zachary Rome - 12 Mar 2024 Form 4 Insider Report for PaxMedica, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 12 Mar 2024
- Net transaction value
- -$3,384
- SEC form
- 4
- Accepted by SEC
- 14 Mar 2024, 16:48:37 UTC
- Prior SEC filing
- 31 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen D. Sheldon, Jr. Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Zachary Rome filed Form 4 for PaxMedica, Inc. on 14 Mar 2024.
Change
- Previous filing in this sequence was filed on 31 Jan 2024.
- Current net transaction value: -$3,384.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PXMD
transaction
Common Stock
Tax liability
- Transaction value
- $3,384
- Shares
- -4,904
- Change %
- -32%
- Price
- $0.6900
- Shares after
- 10,244
- Date
- 12 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.